Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?

BACKGROUND: Pulmonary infections caused by non-tuberculous mycobacteria (NTM) are hard to treat and have low cure rates despite intensive multidrug therapy. OBJECTIVES: To assess the feasibility of tedizolid, a new oxazolidinone, for the treatment of Mycobacterium avium and Mycobacterium abscessus....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Ruth, Mike Marvin, Koeken, Valerie A C M, Pennings, Lian J, Svensson, Elin M, Wertheim, Heiman F L, Hoefsloot, Wouter, van Ingen, Jakko
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021090/
https://ncbi.nlm.nih.gov/pubmed/31886864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz511
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi